Brian M. Gallagher Jr., Director at eFFECTOR Therapeutics, Inc. (EFTR), bought 30,000 shares at $1.59 ($48K) on 2022-06-23, disclosed to the SEC on 2022-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |